These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2039994)

  • 1. Abrogation of interferon-induced resistance to interferon-activated major histocompatibility complex-unrestricted killers by treatment of a melanoma cell line with 5-fluorouracil.
    Neefe JR; Glass J
    Cancer Res; 1991 Jun; 51(12):3159-63. PubMed ID: 2039994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
    Stanková J; Rola-Pleszczynski M
    J Immunol; 1985 Dec; 135(6):3719-28. PubMed ID: 2415584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
    Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
    Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.
    Stötter H; Wiebke EA; Tomita S; Belldegrun A; Topalian S; Rosenberg SA; Lotze MT
    J Immunol; 1989 Mar; 142(5):1767-73. PubMed ID: 2493053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T; Sone S
    J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells.
    De Filippi R; Prete SP; Giuliani A; Silvi E; Yamaue H; Nieroda CA; Greiner JW; De Vecchis L; Bonmassar E
    Anticancer Res; 1994; 14(5A):1767-73. PubMed ID: 7847809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells.
    Handgretinger R; Kimmig A; Lang P; Daurer B; Kuci S; Bruchelt G; Treuner J; Niethammer D
    Nat Immun Cell Growth Regul; 1989; 8(4):189-96. PubMed ID: 2507905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
    Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
    Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z
    Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde.
    Okubo A; Sone S; Tanaka M; Ogura T
    Cancer Res; 1989 Jan; 49(2):265-70. PubMed ID: 2463072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
    Ohmura K; Tsukamoto T
    Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human natural killer activity in selected test systems and tissue compartments: natural killer cell modulation by biological response modifiers].
    Klappacher G
    Wien Klin Wochenschr; 1988 Nov; 100(22):743-6. PubMed ID: 3149079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
    Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
    Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induction of human monocyte-mediated tumor cell killing by alpha or beta interferon].
    Utsugi T; Mutsuura S; Ogawara M; Shirahama T; Ishii K; Tsubura E; Sone S
    Gan To Kagaku Ryoho; 1985 May; 12(5):1105-10. PubMed ID: 3994398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity.
    Webb DS; Gerrard TL
    J Immunol; 1990 May; 144(9):3643-8. PubMed ID: 2158515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.
    Thiele DL; Patel SS; Lipsky PE
    J Immunol; 1988 May; 140(9):3253-60. PubMed ID: 2966209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.